Darn right AVNR isn't CELG because CELG has earnings of almost $1.5 billion and AVNR has losses of $50 million. Avanir had quarterly sales of $10 million and Celgene had quarterly sales of $1.2 billion. At Avanir's peak they will be lucky to get $150 million in annual sales because those survey's were the biggest lies ever.
Your garbage is as bad as Tradestoxx calling Avanir with their drug that is doing $10 million in quarterly sales the next Apple.
So the morale of your story is we have to wait 20 years to make any money on Avanir. So you are saying we should risk everything we have on this risky biotech stock and just hope it pays off and they aren't one of the 90% of the biotech stocks that fail. Great lets put all our money into a company that sells one drug that helps people who have uncontrollable laughing and crying.